文献速递糖尿病肥胖与代谢综合征

COVID-19大流行期间儿童和青少年2型糖尿病趋势的变化

Changes in Type 2 Diabetes Trends in Children and Adolescents During the COVID-19 Pandemic.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

该研究回顾性分析了美国阿拉巴马州一家医院的642例新发儿童2型糖尿病患者,比较COVID-19前后月均新发病例数及患者特征。COVID-19期间月均新发病例数较前显著增加,主要归因于医疗补助(Medicaid)参保者,男性比例亦上升。

要点

  • COVID-19期间儿童2型糖尿病月均新发病例数较前显著增加(19.3±7.8 vs 11.1±3.8,P=0.004)。
  • 医疗补助参保患者月均新发病例数在COVID-19期间显著增加(15.3±6.6 vs 7.9±3.4,P=0.003)。
  • 非医疗补助患者月均新发病例数无显著变化,男性比例从36.8%升至46.1%(P=0.021)。

核心结论

  • COVID-19大流行期间阿拉巴马州青少年中新发2型糖尿病有所增加,且该负担不成比例地影响了医疗补助参保者和男性。

研究设计与样本

  • 回顾性单中心病历审查,纳入2017年3月至2021年3月转诊的新发2型糖尿病患者,共642例。

主要发现

  • COVID-19前月均新发病例数为11.1±3.8,COVID-19期间为19.3±7.8(P=0.004)。
  • 医疗补助患者月均新发病例数COVID-19前为7.9±3.4,期间为15.3±6.6(P=0.003)。
  • 非医疗补助患者月均新发病例数COVID-19前为3.3±1.7,期间为4.0±2.4(P=0.33)。
  • 回归分析显示COVID-19期间全样本月均新发病例数增加(β=5.93,P<0.05),医疗补助参保者亦增加(β=5.42,P<0.05)。
  • 住院率、肥胖严重程度和血红蛋白A1c在COVID-19前后保持相似,但男性患者比例从36.8%升至46.1%(P=0.021)。

关键数值与推荐

  • COVID-19期间月均新发病例数较前增加(19.3±7.8 vs 11.1±3.8,P=0.004)。
  • 医疗补助患者月均新发病例数COVID-19期间较前增加(15.3±6.6 vs 7.9±3.4,P=0.003);非医疗补助患者无显著差异(4.0±2.4 vs 3.3±1.7,P=0.33)。
  • 全样本月均新发病例数COVID-19期间较前增加(β=5.93,P<0.05);医疗补助参保者亦增加(β=5.42,P<0.05)。
  • 男性患者比例COVID-19期间较前升高(46.1% vs 36.8%,P=0.021)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: There is concern that the growing incidence of pediatric type 2 diabetes (T2D) may have been further exacerbated by the COVID-19 pandemic. OBJECTIVE: To examine whether trends in new-onset pediatric T2D-inclusive of patients requiring hospitalization and patients managed as outpatients-were impacted during the COVID-19 pandemic, and to compare patient characteristics prior to and during COVID-19. METHODS: A retrospective single-center medical record review was conducted in a hospital which cares for 90% of Alabama's pediatric T2D patients. Patients with new-onset T2D referred from March 2017 to March 2021 were included. Counts of patients presenting per month ("monthly rates") were computed. Linear regression models were estimated for the full sample and stratified by Medicaid and non-Medicaid insurance status. Patient characteristics prior to vs during COVID-19 were compared. RESULTS: A total of 642 patients presented with new-onset T2D over this period. Monthly rates were 11.1 ± 3.8 prior to COVID-19 and 19.3 ± 7.8 during COVID-19 (P = .004). Monthly rates for Medicaid patients differed prior to and during COVID-19 (7.9 ± 3.4 vs 15.3 ± 6.6, P = .003) but not for non-Medicaid patients (3.3 ± 1.7 vs 4.0 ± 2.4, P = .33). Regression results showed significant increases in monthly rates during COVID-19 for the full sample (β= 5.93, P < .05) and for Medicaid enrollees (β= 5.42, P < .05) Hospitalization rate, severity of obesity, and hemoglobin A1c remained similar prior to and during COVID-19, though the proportion of male patients increased from 36.8% to 46.1% (P = .021). CONCLUSIONS: A rise in new-onset T2D was observed among Alabama's youth during the COVID-19 pandemic, a burden that disproportionately affected Medicaid enrollees and males. Future research should explore the pathways through which the pandemic impacted pediatric T2D.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Schmitt JA, Ashraf AP, Becker DJ, et al. Changes in Type 2 Diabetes Trends in Children and Adolescents During the COVID-19 Pandemic. J Clin Endocrinol Metab. 2022. PMID: 35377436. doi:10.1210/clinem/dgac209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。